Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats
Jing Li, Yanyan Qiu, Yanan Zhang, et al.
Drug and Alcohol Dependence (2014) Vol. 143, pp. 251-256
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Bogna M. Ignatowska‐Jankowska, Gemma L. Baillie, Steven G. Kinsey, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 13, pp. 2948-2959
Open Access | Times Cited: 151
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen, Jun‐Xu Li, Brian F. Thomas, et al.
Medicinal Research Reviews (2016) Vol. 37, Iss. 3, pp. 441-474
Open Access | Times Cited: 89
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, et al.
Handbook of experimental pharmacology (2019), pp. 323-353
Open Access | Times Cited: 73
Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities
Leepakshi Khurana, Ken Mackie, Daniele Piomelli, et al.
Neuropharmacology (2017) Vol. 124, pp. 3-12
Open Access | Times Cited: 72
Design, Synthesis, and Structure–Activity Relationship Study of Novel Indole-2-carboxamide Derivatives as Anti-inflammatory Agents for the Treatment of Sepsis
Zhiguo Liu, Longguang Tang, Heping Zhu, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 10, pp. 4637-4650
Closed Access | Times Cited: 65
Roles for the endocannabinoid system in ethanol-motivated behavior
Angela N. Henderson‐Redmond, Josée Guindon, Daniel J. Morgan
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 65, pp. 330-339
Open Access | Times Cited: 61
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?
Kari A. Johnson, David M. Lovinger
Frontiers in Cellular Neuroscience (2016) Vol. 10
Open Access | Times Cited: 58
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Scalable, One-Pot, Microwave-Accelerated Tandem Synthesis of Unsymmetrical Urea Derivatives
Abhijit Kulkarni, Sumanta Garai, Ganesh A. Thakur
The Journal of Organic Chemistry (2016) Vol. 82, Iss. 2, pp. 992-999
Closed Access | Times Cited: 49
Development of Squaramides as Allosteric Modulators of the CB1 Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats
Thuy Nguyen, Ann M. Decker, Daniel G. Barrus, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation
Cristina Aparecida Jark Stern, Cristiane Ribeiro de Carvalho, Leandro J. Bertoglio, et al.
Neuroscience (2017) Vol. 370, pp. 62-80
Closed Access | Times Cited: 48
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
Xianghu He, Chloe J. Jordan, Kiran Vemuri, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 365-373
Open Access | Times Cited: 46
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
Dai Lu, Sri Sujana Immadi, Zhixing Wu, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 324-335
Open Access | Times Cited: 39
Pyrimidinyl Biphenylureas: Identification of New Lead Compounds as Allosteric Modulators of the Cannabinoid Receptor CB1
Leepakshi Khurana, Boqiao Fu, Anantha Lakshmi Duddupudi, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1089-1104
Open Access | Times Cited: 39
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats
Jayme R. McReynolds, Elizabeth M. Doncheck, Oliver Vranjkovic, et al.
Psychopharmacology (2015) Vol. 233, Iss. 1, pp. 99-109
Open Access | Times Cited: 37
Structure–activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators
Thuy Nguyen, Nadezhda German, Ann M. Decker, et al.
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 9, pp. 2195-2203
Open Access | Times Cited: 36
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure
Leigh V. Panlilio, Zuzana Justinová
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 116-141
Open Access | Times Cited: 34
Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity
Rachel Dopart, Dai Lu, Aron H. Lichtman, et al.
Drug Metabolism Reviews (2018) Vol. 50, Iss. 1, pp. 3-13
Open Access | Times Cited: 33
Allosteric Modulators Targeting Cannabinoid cb1 and cb2 Receptors: Implications for Drug Discovery
Francesca Gado, Serena Meini, Simone Bertini, et al.
Future Medicinal Chemistry (2019) Vol. 11, Iss. 15, pp. 2019-2037
Open Access | Times Cited: 30
Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self‐administration and relapse in mice
Idaira Oliva, Fezaan Kazi, Lucas Cantwell, et al.
Addiction Biology (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 3
The future of type 1 cannabinoid receptor allosteric ligands
Mariam Alaverdashvili, Robert B. Laprairie
Drug Metabolism Reviews (2018) Vol. 50, Iss. 1, pp. 14-25
Closed Access | Times Cited: 28
mGlu5 function in the nucleus accumbens core during the incubation of methamphetamine craving
Conor H. Murray, Daniel Christian, Mike Milovanovic, et al.
Neuropharmacology (2021) Vol. 186, pp. 108452-108452
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top